⌘K

Login Start Free

Home/Filings/4/0001055726-18-000030

4//SEC Filing

COLLINS MORTON 4

Accession 0001055726-18-000030

CIK 0001055726other

View on SEC.gov Company Profile

Filed

May 13, 8:00 PM ET

Accepted

May 14, 6:06 PM ET

Size

15.2 KB

Accession

0001055726-18-000030

Insider Transaction Report

Form 4

Period: 2018-05-11

INOVIO PHARMACEUTICALS, INC.INO

Director

Transactions

Award
Restricted Stock Unit
2018-05-11+8,170→ 8,170 total
→ Common Stock (8,170 underlying)
Exercise/Conversion
Restricted Stock Unit
2018-05-12−7,669→ 0 total
→ Common Stock (7,669 underlying)
Exercise/Conversion
Common Stock
2018-05-12+7,669→ 159,960 total
Award
Common Stock Option
2018-05-11+12,500→ 12,500 total
Exercise: $4.56Exp: 2028-05-11→ Common Stock (12,500 underlying)

Holdings

Common Stock
(indirect: By IRA)
50,000
Common Stock
(indirect: By Trust)
64,750
Common Stock
(indirect: By Spouse)
6,650
Common Stock
(indirect: By Spouse)
6,450
Common Stock
(indirect: By Trust)
64,750
Common Stock
(indirect: By Trust)
4,500

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018.
[F2]Options to vest 100% on May 11, 2019.
[F3]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019.

Documents

1 file

4
wf-form4_152633558486739.xmlPrimary
FORM 4

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

Entity typeother

Related Parties

1

filerCIK 0001238716

Filing Metadata

Form type: 4
Filed: May 13, 8:00 PM ET
Accepted: May 14, 6:06 PM ET
Size: 15.2 KB

View on SEC.gov